Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 146 entries
Sorted by: Best Match Show Resources per page
Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes.

Nature biomedical engineering

Wan Y, Cheng G, Liu X, Hao SJ, Nisic M, Zhu CD, Xia YQ, Li WQ, Wang ZG, Zhang WL, Rice SJ, Sebastian A, Albert I, Belani CP, Zheng SY.
PMID: 28966872
Nat Biomed Eng. 2017;1. doi: 10.1038/s41551-017-0058. Epub 2017 Apr 10.

Extracellular vesicles (EVs) can mediate intercellular communication by transferring cargo proteins and nucleic acids between cells. The pathophysiological roles and clinical value of EVs are under intense investigation, yet most studies are limited by technical challenges in the isolation...

Cite
Wan Y, Cheng G, Liu X, et al. Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nat Biomed Eng. 2017;1doi: 10.1038/s41551-017-0058.
Wan, Y., Cheng, G., Liu, X., Hao, S. J., Nisic, M., Zhu, C. D., Xia, Y. Q., Li, W. Q., Wang, Z. G., Zhang, W. L., Rice, S. J., Sebastian, A., Albert, I., Belani, C. P., & Zheng, S. Y. (2017). Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nature biomedical engineering, 1. https://doi.org/10.1038/s41551-017-0058
Wan, Yuan, et al. "Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes." Nature biomedical engineering vol. 1 (2017). doi: https://doi.org/10.1038/s41551-017-0058
Wan Y, Cheng G, Liu X, Hao SJ, Nisic M, Zhu CD, Xia YQ, Li WQ, Wang ZG, Zhang WL, Rice SJ, Sebastian A, Albert I, Belani CP, Zheng SY. Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nat Biomed Eng. 2017;1. doi: 10.1038/s41551-017-0058. Epub 2017 Apr 10. PMID: 28966872; PMCID: PMC5618714.
Copy Download .nbib Format: NLM
Neighborhood Stress and Life Satisfaction: Is there a Relationship for African American Adolescents?.

Applied research in quality of life

Valois RF, Kerr JC, Carey MP, Brown LK, Romer D, DiClemente RJ, Vanable PA.
PMID: 32042351
Appl Res Qual Life. 2020 Mar;15(1):273-296. doi: 10.1007/s11482-018-9679-z.

This study identified associations between perceived neighborhood stress and adolescents' perceptions of life satisfaction. African American adolescents aged 13-18 (

Cite
Valois RF, Kerr JC, Carey MP, et al. Neighborhood Stress and Life Satisfaction: Is there a Relationship for African American Adolescents?. Appl Res Qual Life. 2020;15(1):273-296doi: 10.1007/s11482-018-9679-z.
Valois, R. F., Kerr, J. C., Carey, M. P., Brown, L. K., Romer, D., DiClemente, R. J., & Vanable, P. A. (2020). Neighborhood Stress and Life Satisfaction: Is there a Relationship for African American Adolescents?. Applied research in quality of life, 15(1), 273-296. https://doi.org/10.1007/s11482-018-9679-z
Valois, Robert F, et al. "Neighborhood Stress and Life Satisfaction: Is there a Relationship for African American Adolescents?." Applied research in quality of life vol. 15,1 (2020): 273-296. doi: https://doi.org/10.1007/s11482-018-9679-z
Valois RF, Kerr JC, Carey MP, Brown LK, Romer D, DiClemente RJ, Vanable PA. Neighborhood Stress and Life Satisfaction: Is there a Relationship for African American Adolescents?. Appl Res Qual Life. 2020 Mar;15(1):273-296. doi: 10.1007/s11482-018-9679-z. PMID: 32042351; PMCID: PMC7009313.
Copy Download .nbib Format: NLM
ERAS - The dawn of a new era!.

Journal of anaesthesiology, clinical pharmacology

Gopinath R, Belani KG.
PMID: 31142951
J Anaesthesiol Clin Pharmacol. 2019 Apr;35:S1-S2. doi: 10.4103/joacp.JOACP_56_19.

No abstract available.

Cite
Gopinath R, Belani KG. ERAS - The dawn of a new era!. J Anaesthesiol Clin Pharmacol. 2019;35:S1-S2doi: 10.4103/joacp.JOACP_56_19.
Gopinath, R., & Belani, K. G. (2019). ERAS - The dawn of a new era!. Journal of anaesthesiology, clinical pharmacology, 35S1-S2. https://doi.org/10.4103/joacp.JOACP_56_19
Gopinath, Ramachandran, and Belani, Kumar G. "ERAS - The dawn of a new era!." Journal of anaesthesiology, clinical pharmacology vol. 35 (2019): S1-S2. doi: https://doi.org/10.4103/joacp.JOACP_56_19
Gopinath R, Belani KG. ERAS - The dawn of a new era!. J Anaesthesiol Clin Pharmacol. 2019 Apr;35:S1-S2. doi: 10.4103/joacp.JOACP_56_19. PMID: 31142951; PMCID: PMC6515721.
Copy Download .nbib Format: NLM
Goal-directed fluid therapy in the perioperative setting.

Journal of anaesthesiology, clinical pharmacology

Kendrick JB, Kaye AD, Tong Y, Belani K, Urman RD, Hoffman C, Liu H.
PMID: 31142956
J Anaesthesiol Clin Pharmacol. 2019 Apr;35:S29-S34. doi: 10.4103/joacp.JOACP_26_18.

Improvement in patient outcomes has become a significant consideration with our limited resources in the surgical setting. The implementation of enhanced recovery pathway protocols has resulted in significant benefits to both the patients and hospitals, such as shorter length...

Cite
Kendrick JB, Kaye AD, Tong Y, et al. Goal-directed fluid therapy in the perioperative setting. J Anaesthesiol Clin Pharmacol. 2019;35:S29-S34doi: 10.4103/joacp.JOACP_26_18.
Kendrick, J. B., Kaye, A. D., Tong, Y., Belani, K., Urman, R. D., Hoffman, C., & Liu, H. (2019). Goal-directed fluid therapy in the perioperative setting. Journal of anaesthesiology, clinical pharmacology, 35S29-S34. https://doi.org/10.4103/joacp.JOACP_26_18
Kendrick, Julia B, et al. "Goal-directed fluid therapy in the perioperative setting." Journal of anaesthesiology, clinical pharmacology vol. 35 (2019): S29-S34. doi: https://doi.org/10.4103/joacp.JOACP_26_18
Kendrick JB, Kaye AD, Tong Y, Belani K, Urman RD, Hoffman C, Liu H. Goal-directed fluid therapy in the perioperative setting. J Anaesthesiol Clin Pharmacol. 2019 Apr;35:S29-S34. doi: 10.4103/joacp.JOACP_26_18. PMID: 31142956; PMCID: PMC6515723.
Copy Download .nbib Format: NLM
Paediatric patients in mass casualty incidents: a comprehensive review and call to action.

British journal of anaesthesia

Desmond M, Schwengel D, Chilson K, Rusy D, Ingram K, Ambardekar A, Greenberg RS, Belani K, Perate A, Gangadharan M.
PMID: 34862001
Br J Anaesth. 2022 Feb;128(2):e109-e119. doi: 10.1016/j.bja.2021.10.026. Epub 2021 Nov 30.

The paediatric population is disproportionately affected during mass casualty incidents (MCIs). Several unique characteristics of children merit special attention during natural and man-made disasters because of their age, physiology, and vulnerability. Paediatric anaesthesiologists play a critical part of MCI...

Cite
Desmond M, Schwengel D, Chilson K, et al. Paediatric patients in mass casualty incidents: a comprehensive review and call to action. Br J Anaesth. 2021;128(2):e109-e119doi: 10.1016/j.bja.2021.10.026.
Desmond, M., Schwengel, D., Chilson, K., Rusy, D., Ingram, K., Ambardekar, A., Greenberg, R. S., Belani, K., Perate, A., Gangadharan, M. (2022). Paediatric patients in mass casualty incidents: a comprehensive review and call to action. British journal of anaesthesia, 128(2), e109-e119. https://doi.org/10.1016/j.bja.2021.10.026
Desmond, Matthew, et al. "Paediatric patients in mass casualty incidents: a comprehensive review and call to action." British journal of anaesthesia vol. 128,2 (2022): e109-e119. doi: https://doi.org/10.1016/j.bja.2021.10.026
Desmond M, Schwengel D, Chilson K, Rusy D, Ingram K, Ambardekar A, Greenberg RS, Belani K, Perate A, Gangadharan M. Paediatric patients in mass casualty incidents: a comprehensive review and call to action. Br J Anaesth. 2022 Feb;128(2):e109-e119. doi: 10.1016/j.bja.2021.10.026. Epub 2021 Nov 30. PMID: 34862001.
Copy Download .nbib Format: NLM
Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure.

Leukemia & lymphoma

Melani C, Wilson WH.
PMID: 34763592
Leuk Lymphoma. 2021 Nov 11;1-3. doi: 10.1080/10428194.2021.2002323. Epub 2021 Nov 11.

No abstract available.

Cite
Melani C, Wilson WH. Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure. Leuk Lymphoma. 2021;1-3doi: 10.1080/10428194.2021.2002323.
Melani, C., & Wilson, W. H. (2021). Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure. Leukemia & lymphoma, 1-3. https://doi.org/10.1080/10428194.2021.2002323
Melani, Christopher, and Wilson, Wyndham H. "Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure." Leukemia & lymphoma vol. (2021): 1-3. doi: https://doi.org/10.1080/10428194.2021.2002323
Melani C, Wilson WH. Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure. Leuk Lymphoma. 2021 Nov 11;1-3. doi: 10.1080/10428194.2021.2002323. Epub 2021 Nov 11. PMID: 34763592.
Copy Download .nbib Format: NLM
Transapical ProtekDuo Rapid Deployment Cannula as Temporary Left Ventricular Assist Device in a Jehovah's Witness Patient.

Journal of cardiothoracic and vascular anesthesia

Belani K, Saikus CE, Schroder JN, Klinger RY.
PMID: 33388220
J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3735-3742. doi: 10.1053/j.jvca.2020.12.009. Epub 2020 Dec 13.

Temporary left ventricular support aims to decompress the left ventricle and provide adequate forward flow into the arterial circulation. This can be accomplished with endovascular devices such as the Impella with an internal motor, or with the implementation of...

Cite
Belani K, Saikus CE, Schroder JN, et al. Transapical ProtekDuo Rapid Deployment Cannula as Temporary Left Ventricular Assist Device in a Jehovah's Witness Patient. J Cardiothorac Vasc Anesth. 2020;35(12):3735-3742doi: 10.1053/j.jvca.2020.12.009.
Belani, K., Saikus, C. E., Schroder, J. N., & Klinger, R. Y. (2021). Transapical ProtekDuo Rapid Deployment Cannula as Temporary Left Ventricular Assist Device in a Jehovah's Witness Patient. Journal of cardiothoracic and vascular anesthesia, 35(12), 3735-3742. https://doi.org/10.1053/j.jvca.2020.12.009
Belani, Kiran, et al. "Transapical ProtekDuo Rapid Deployment Cannula as Temporary Left Ventricular Assist Device in a Jehovah's Witness Patient." Journal of cardiothoracic and vascular anesthesia vol. 35,12 (2021): 3735-3742. doi: https://doi.org/10.1053/j.jvca.2020.12.009
Belani K, Saikus CE, Schroder JN, Klinger RY. Transapical ProtekDuo Rapid Deployment Cannula as Temporary Left Ventricular Assist Device in a Jehovah's Witness Patient. J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3735-3742. doi: 10.1053/j.jvca.2020.12.009. Epub 2020 Dec 13. PMID: 33388220.
Copy Download .nbib Format: NLM
Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.

Cureus

Siddiqui M, Shah PV, Balani P, Lopez AR, Nobleza CMN, Khan S.
PMID: 33643745
Cureus. 2021 Feb 12;13(2):c41. doi: 10.7759/cureus.c41.

[This corrects the article DOI: 10.7759/cureus.13002.].

Cite
Siddiqui M, Shah PV, Balani P, et al. Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines. Cureus. 2021;13(2):c41doi: 10.7759/cureus.c41.
Siddiqui, M., Shah, P. V., Balani, P., Lopez, A. R., Nobleza, C. M. N., & Khan, S. (2021). Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines. Cureus, 13(2), c41. https://doi.org/10.7759/cureus.c41
Siddiqui, Mariah, et al. "Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines." Cureus vol. 13,2 (2021): c41. doi: https://doi.org/10.7759/cureus.c41
Siddiqui M, Shah PV, Balani P, Lopez AR, Nobleza CMN, Khan S. Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines. Cureus. 2021 Feb 12;13(2):c41. doi: 10.7759/cureus.c41. PMID: 33643745; PMCID: PMC7885304.
Copy Download .nbib Format: NLM
Idiopathic membranous occlusion of the foramen of Monro: an unusual cause of hydrocephalus and headache in adults.

British journal of neurosurgery

Chin XS, Morgenstern PF, Belani PB.
PMID: 33410364
Br J Neurosurg. 2021 Jan 07;1-3. doi: 10.1080/02688697.2020.1866167. Epub 2021 Jan 07.

Occlusion of foramen of Monro is an uncommon clinical entity that usually presents in children. Common causes are obstructing mass, infectious etiologies or vascular malformation. Rarely, it may be an idiopathic stricture or membrane. We report a case of...

Cite
Chin XS, Morgenstern PF, Belani PB. Idiopathic membranous occlusion of the foramen of Monro: an unusual cause of hydrocephalus and headache in adults. Br J Neurosurg. 2021;1-3doi: 10.1080/02688697.2020.1866167.
Chin, X. S., Morgenstern, P. F., & Belani, P. B. (2021). Idiopathic membranous occlusion of the foramen of Monro: an unusual cause of hydrocephalus and headache in adults. British journal of neurosurgery, 1-3. https://doi.org/10.1080/02688697.2020.1866167
Chin, Xing S, et al. "Idiopathic membranous occlusion of the foramen of Monro: an unusual cause of hydrocephalus and headache in adults." British journal of neurosurgery vol. (2021): 1-3. doi: https://doi.org/10.1080/02688697.2020.1866167
Chin XS, Morgenstern PF, Belani PB. Idiopathic membranous occlusion of the foramen of Monro: an unusual cause of hydrocephalus and headache in adults. Br J Neurosurg. 2021 Jan 07;1-3. doi: 10.1080/02688697.2020.1866167. Epub 2021 Jan 07. PMID: 33410364.
Copy Download .nbib Format: NLM
Artificial hydration at the end of life: balancing benefits and risks in the absence of conclusive evidence.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Beland P.
PMID: 32875752
Nurs Stand. 2020 Nov 04;35(11):61-65. doi: 10.7748/ns.2020.e11595. Epub 2020 Sep 02.

There is a lack of clear evidence regarding the benefits and harm of artificial hydration at the end of life. Trial findings are conflicting and inconclusive, offering little basis for recommendations. As a result, the advantages and disadvantages of...

Cite
Beland P. Artificial hydration at the end of life: balancing benefits and risks in the absence of conclusive evidence. Nurs Stand. 2020;35(11):61-65doi: 10.7748/ns.2020.e11595.
Beland, P. (2020). Artificial hydration at the end of life: balancing benefits and risks in the absence of conclusive evidence. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 35(11), 61-65. https://doi.org/10.7748/ns.2020.e11595
Beland, Paul. "Artificial hydration at the end of life: balancing benefits and risks in the absence of conclusive evidence." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 35,11 (2020): 61-65. doi: https://doi.org/10.7748/ns.2020.e11595
Beland P. Artificial hydration at the end of life: balancing benefits and risks in the absence of conclusive evidence. Nurs Stand. 2020 Nov 04;35(11):61-65. doi: 10.7748/ns.2020.e11595. Epub 2020 Sep 02. PMID: 32875752.
Copy Download .nbib Format: NLM
Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting.

The Prostate

Miyahira AK, Zarif JC, Coombs CC, Flavell RR, Russo JW, Zaidi S, Zhao D, Zhao SG, Pienta KJ, Soule HR.
PMID: 34734426
Prostate. 2022 Feb;82(2):169-181. doi: 10.1002/pros.24262. Epub 2021 Nov 03.

INTRODUCTION: The 2021 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Prostate Cancer Research in the 21st Century," was held virtually, from June 24-25, 2021.METHODS: The CHPCA Meeting is organized by the Prostate Cancer Foundation as a unique discussion-oriented meeting focusing...

Cite
Miyahira AK, Zarif JC, Coombs CC, et al. Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting. Prostate. 2021;82(2):169-181doi: 10.1002/pros.24262.
Miyahira, A. K., Zarif, J. C., Coombs, C. C., Flavell, R. R., Russo, J. W., Zaidi, S., Zhao, D., Zhao, S. G., Pienta, K. J., & Soule, H. R. (2022). Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting. The Prostate, 82(2), 169-181. https://doi.org/10.1002/pros.24262
Miyahira, Andrea K, et al. "Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting." The Prostate vol. 82,2 (2022): 169-181. doi: https://doi.org/10.1002/pros.24262
Miyahira AK, Zarif JC, Coombs CC, Flavell RR, Russo JW, Zaidi S, Zhao D, Zhao SG, Pienta KJ, Soule HR. Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting. Prostate. 2022 Feb;82(2):169-181. doi: 10.1002/pros.24262. Epub 2021 Nov 03. PMID: 34734426.
Copy Download .nbib Format: NLM
Withdrawal Notice: EnzyPha, an Engineered Helper Phage Developed to Overcome Most of the Limitations Regarding Filamentous Phage Titration and ELISA Tests.

Protein and peptide letters

Mohammadi M, Fouladvand F, Bemani P, Amini R, Jalilian FA.
PMID: 33172367
Protein Pept Lett. 2020 Nov 10; doi: 10.2174/0929866527666201110124420. Epub 2020 Nov 10.

The article has been withdrawn at the request of the authors of the journal Protein & Peptide Letters. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on...

Cite
Mohammadi M, Fouladvand F, Bemani P, et al. Withdrawal Notice: EnzyPha, an Engineered Helper Phage Developed to Overcome Most of the Limitations Regarding Filamentous Phage Titration and ELISA Tests. Protein Pept Lett. 2020;doi: 10.2174/0929866527666201110124420.
Mohammadi, M., Fouladvand, F., Bemani, P., Amini, R., & Jalilian, F. A. (2020). Withdrawal Notice: EnzyPha, an Engineered Helper Phage Developed to Overcome Most of the Limitations Regarding Filamentous Phage Titration and ELISA Tests. Protein and peptide letters, . https://doi.org/10.2174/0929866527666201110124420
Mohammadi, Mozafar, et al. "Withdrawal Notice: EnzyPha, an Engineered Helper Phage Developed to Overcome Most of the Limitations Regarding Filamentous Phage Titration and ELISA Tests." Protein and peptide letters vol. (2020). doi: https://doi.org/10.2174/0929866527666201110124420
Mohammadi M, Fouladvand F, Bemani P, Amini R, Jalilian FA. Withdrawal Notice: EnzyPha, an Engineered Helper Phage Developed to Overcome Most of the Limitations Regarding Filamentous Phage Titration and ELISA Tests. Protein Pept Lett. 2020 Nov 10; doi: 10.2174/0929866527666201110124420. Epub 2020 Nov 10. PMID: 33172367.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 146 entries